Skip to main content
. Author manuscript; available in PMC: 2022 Jul 28.
Published in final edited form as: Cytoskeleton (Hoboken). 2021 Jul 28;78(6):312–322. doi: 10.1002/cm.21680

Table 1.

Survey of papers that reported cancer cell responses (proliferation, migration and apoptosis) to solid compressive stress or hydrostatic pressure. Model systems used, magnitude of stress and time of stress application are also included.

Cancer Cell type Type of model Mechanical Stress Stress parameters Effect on Ref.
2D In vitro culture 3D culture Solid compressive stress Hydrostatic pressure Magnitude (mm Hg) Duration Proliferation Migration Apoptosis
H4
Brain tumor
60 21 d (Kalli, Voutouri, et al., 2019)
A172
Brain tumor
26 21 d (Kalli, Voutouri, et al., 2019)
MDA-MB 231
Breast cancer
6 d (Chun Liu, Lewin Mejia, Chiang, Luker, & Luker, 2018)
HCT116
Colorectal cancer
No change (Desmaison et al., 2013)
HT29
Human colon carcinoma
35 –75 No change (Delarue et al., 2014)
CT26
Mouse colon adenocarcinoma
35 –75 (Delarue et al., 2014)
BC52
Human breast cancer
35 –75 (Delarue et al., 2014)
AB6
Mouse sarcoma
35 –75 (Delarue et al., 2014)
LS174T
Human colon adenocarcinoma
45 –120 30 d No change (Helmlinger et al., 1997)
4T1, 67NR,
MDA-MB 231
Breast cancer
5.8 16 h (Janet M. Tse et al., 2012)
MCF 10A, MCF7
Breast cancer
5.8 16 h (Janet M. Tse et al., 2012)
67NR
Breast cancer
> 5.8 –58 16 h (Cheng et al., 2009; Janet M. Tse et al., 2012)
H4
Brain tumor (Glioma)
4 16 h (Kalli, Voutouri, et al., 2019)
A172
Brain tumor
4 16 h No change (Kalli, Voutouri, et al., 2019)
CFPAC-1 (Pancreatic cancer) 1–6 6 h (Kalli et al., 2018)
PaCa-2/BxPC-3
(Pancreatic cancer)
4 16 h (Kalli, Minia, et al., 2019)
hTRET-AM
Ameloblastoma epithelial cells
30 –90 (Yang et al., 2018)
CL1–5 & A549
Lung cancer cells
0 –20 8 h (Y. Kao, C. Lee, & P. Kuo, 2014; Kao et al., 2017)
SCC-4/SCC-9
Oral squamous carcinoma
0 –30 24 h (T. Yu et al., 2013)
U2OS
Osteosarcoma
0 –50 72 h (DiResta et al., 2005; Nathan et al., 2005)
SaOS2
Osteosarcoma
0 –50 72 h (DiResta et al., 2005)
HOS
Osteosarcoma
0 –100 72 h (DiResta et al., 2005; Nathan et al., 2005)
MCF7
Breast cancer
0–100 72 h (DiResta et al., 2005)
H1299
Lung carcinoma
0–100 72 h (DiResta et al., 2005)
A431/A 549
Epithelial tumor
In vivo 10/5 (Hofmann et al., 2006)